08045800513
Send Inquiry
Send InquiryLevocetirizine 5 Mg & Montelukast 10 Mg (Dispersible)
Levocetirizine 5 Mg & Montelukast 10 Mg (Dispersible) Specification
- Drug Type
- Generic Drugs
- Ingredients
- Levocetirizine 5 Mg & Montelukast 10 Mg
- Physical Form
- Tablets
- Function
- Improve Breathing Disorders
- Recommended For
- Asthma, Seasonal Allergies & Rhinitis
- Dosage
- Once daily
- Suitable For
- Adults, Aged Person
Levocetirizine 5 Mg & Montelukast 10 Mg (Dispersible) Trade Information
- Minimum Order Quantity
- 500 Boxes
- Payment Terms
- Telegraphic Transfer (T/T)
- Supply Ability
- 100000 Boxes Per Month
- Delivery Time
- 4 Week
- Packaging Details
- Alu-Alu,10*10
- Main Export Market(s)
- Western Europe, Australia, North America, Eastern Europe, Middle East, Central America, Africa, South America, Asia
- Main Domestic Market
- All India
- Certifications
- WHO-GMP
About Levocetirizine 5 Mg & Montelukast 10 Mg (Dispersible)
Levocetirizine 5 Mg & Montelukast 10 Mg (Dispersible) tablets offer a reliable solution for adults and aged persons struggling with respiratory conditions such as asthma, seasonal allergies, and rhinitis. This dual-action medication combines Levocetirizine, a potent antihistamine, and Montelukast, an effective leukotriene receptor antagonist, to reduce inflammation and provide long-lasting relief from breathing disorders. Designed as dispersible tablets, they are convenient to consume and rapidly absorbed. Administered once daily, these generic drugs promote better respiratory health and an improved quality of life. As an exporter, manufacturer, and supplier, this product ensures high efficacy, making it a go-to choice for managing respiratory challenges. ---
FAQs of Levocetirizine 5 Mg & Montelukast 10 Mg (Dispersible):
Q: What is the primary function of Levocetirizine 5 Mg & Montelukast 10 Mg tablets?
A: The tablets work to improve breathing disorders by alleviating asthma symptoms, seasonal allergies, and rhinitis.Q: What is the recommended dosage for this product?
A: The dosage is once daily, ensuring ease of use and effective results.Q: What type of drug is this?
A: It is classified as a generic drug combining antihistamine and anti-inflammatory properties.Q: Who is this product suitable for?
A: The tablets are suitable for adults and aged persons dealing with respiratory issues.Q: What are the key ingredients in this medication?
A: The formulation includes Levocetirizine 5 Mg and Montelukast 10 Mg.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Respiratory Drugs Category
Montelukast Sodium 10 mg & Rupatadine 10 mg
Minimum Order Quantity : 500 Boxes
Physical Form : Tablets
Function : Improve Breathing Disorders
Recommended For : Seasonal Allergies,Rhinitis
Ingredients : Montelukast Sodium 10 mg & Rupatadine 10 mg
Acebrophylline 100 Mg Tablets
Price Range 10.00 - 80.00 INR
Minimum Order Quantity : 500 Boxes
Physical Form : Tablets
Function : Treat ENT Issues
Recommended For : Bronchial Obsturction,Cough
Ingredients : Acebrophylline 100 Mg
Levocetirizine 50 Mg & Ambroxol 75 Mg Tablet
Price Range 10.00 - 80.00 INR
Minimum Order Quantity : 500 Boxes
Physical Form : Tablets
Function : Other
Recommended For : Nasal Congestion, Seasonal & perennial rhinitis
Ingredients : Levocetirizine 50 Mg & Ambroxol 75 Mg
Roxithromycin 150 Mg & Ambroxol 30 Mg Tablets
Price Range 10.00 - 80.00 INR
Minimum Order Quantity : 500 Boxes
Physical Form : Tablets
Function : Improve Breathing Disorders
Recommended For : Acute Pharyngitis,Tonsillitis,Sinusitis,Acute Bronchitis,Pneumonia
Ingredients : Roxithromycin 150 Mg & Ambroxol 30 Mg
Contact Details
- Plot No. 73, Industrial Area, Phase-2,Chandigarh - 160002, India
- Phone : 08045800513
GST : 04AAHCS5485R1ZJ
- Mr Sanjeev Kumar Sethi (Managing Director)
- Mobile : 08045800513
- cmd@solitairegroup.in
- Mobile :+919815777744
SOLITAIRE PHARMACIA PVT. LTD.
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
